|
| 24862407 | Loss of Sparc in p53-null Astrocytes Promotes Macrophage Activation and Phagocytosis Resulting in Decreased Tumor Size and Tumor Cell Survival. | Brain Pathol | 2015 |
| 24477622 | Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas. | J Neurooncol | 2014 |
| 23144078 | TRAIL conjugated to nanoparticles exhibits increased anti-tumor activities in glioma cells and glioma stem cells in vitro and in vivo. | Neuro Oncol | 2013 |
| 23390502 | MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor. | PLoS One | 2013 |
| 23382286 | PTEN suppresses SPARC-induced pMAPKAPK2 and inhibits SPARC-induced Ser78 HSP27 phosphorylation in glioma. | Neuro Oncol | 2013 |
| 23548312 | Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal. | Oncotarget | 2013 |
| 22114076 | Deletion of the SPARC acidic domain or EGF-like module reduces SPARC-induced migration and signaling through p38 MAPK/HSP27 in glioma. | Carcinogenesis | 2012 |
| 22480225 | Inhibition of HSP27 alone or in combination with pAKT inhibition as therapeutic approaches to target SPARC-induced glioma cell survival. | Mol Cancer | 2012 |
| 22422183 | Correlation of perfusion parameters with genes related to angiogenesis regulation in glioblastoma: a feasibility study. | AJNR Am J Neuroradiol | 2012 |
| 21688302 | Proteolysis of the matricellular protein hevin by matrix metalloproteinase-3 produces a SPARC-like fragment (SLF) associated with neovasculature in a murine glioma model. | J Cell Biochem | 2011 |
| 21788343 | Cilengitide induces autophagy-mediated cell death in glioma cells. | Neuro Oncol | 2011 |
| 20472716 | PTEN augments SPARC suppression of proliferation and inhibits SPARC-induced migration by suppressing SHC-RAF-ERK and AKT signaling. | Neuro Oncol | 2010 |
| 19027948 | Controlling integrin specificity and stem cell differentiation in 2D and 3D environments through regulation of fibronectin domain stability. | Biomaterials | 2009 |
| 18403493 | GRP78 is overexpressed in glioblastomas and regulates glioma cell growth and apoptosis. | Neuro Oncol | 2008 |
| 18442089 | HSP27 mediates SPARC-induced changes in glioma morphology, migration, and invasion. | Glia | 2008 |
| 18350569 | SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretion. | Int J Cancer | 2008 |
| 17490812 | SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells. | Neurosci Lett | 2007 |
| 17344888 | Splenic and immune alterations of the Sparc-null mouse accompany a lack of immune response. | Genes Immun | 2007 |
| 17297440 | PIKE-A is a proto-oncogene promoting cell growth, transformation and invasion. | Oncogene | 2007 |
| 16115889 | SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity. | J Biol Chem | 2005 |
| 15230275 | International Hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactions. | Matrix Biol | 2004 |
| 14555516 | Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers. | Clin Cancer Res | 2003 |
| 14565160 | SPARC affects glioma cell growth differently when grown on brain ECM proteins in vitro under standard versus reduced-serum stress conditions. | Neuro Oncol | 2003 |
| 14555517 | Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival. | Clin Cancer Res | 2003 |
| 11774351 | Studying the heterogeneity of brain tumors using medium throughput LOH analysis. | Cytometry | 2002 |
| 12414657 | Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo. | Cancer Res | 2002 |
| 12510773 | cDNA array analysis of SPARC-modulated changes in glioma gene expression. | J Neurooncol | 2002 |
| 11770303 | Molecular biology of nervous system tumors. | Hematol Oncol Clin North Am | 2001 |
| 11716067 | SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins. | J Neurooncol | 2001 |
| 11696458 | New approaches to the molecular biology, classification, and therapy of nervous system tumors: a workshop of the National Institutes of Health Pathology B study section. | Am J Pathol | 2001 |
| 11692657 | New innovations and developments for glioma treatment. | Clin Neurosurg | 2001 |
| 10778947 | Carboxyamido-triazole induces apoptosis in bovine aortic endothelial and human glioma cells. | Clin Cancer Res | 2000 |
| 11302248 | Use of horizontal ultrathin gel electrophoresis to analyze allelic deletions in chromosome band 11p15.5 in gliomas. | Neuro Oncol | 2000 |
| 10861485 | Targeting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC. | Int J Cancer | 2000 |
| 10995878 | A study of SPARC and vitronectin localization and expression in pediatric and adult gliomas: high SPARC secretion correlates with decreased migration on vitronectin. | Int J Oncol | 2000 |
| 10888600 | Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. | Hum Mol Genet | 2000 |
| 10656438 | Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. | Clin Cancer Res | 2000 |
| 10571408 | Increased SPARC expression promotes U87 glioblastoma invasion in vitro. | Int J Dev Neurosci | 1999 |
| 10037170 | SPARC: a potential diagnostic marker of invasive meningiomas. | Clin Cancer Res | 1999 |
| 9862633 | SPARC: a signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas. | J Neuropathol Exp Neurol | 1998 |
| 10235000 | Expression of transforming growth factor-beta complex in arteriovenous malformations. | Neurol Med Chir (Tokyo) | 1998 |
| 10343969 | Temporal profile of connexin 43 mRNA expression in a tetanus toxin-induced seizure disorder. | Mol Chem Neuropathol | 1998 |
| 10030674 | Novel regions of allelic deletion on chromosome 18p in tumors of the lung, brain and breast. | Oncogene | 1998 |
| 9619352 | Molecular biology of central nervous system tumors. | Curr Opin Oncol | 1998 |
| 9437659 | Connexin 43 mRNA expression in two experimental models of epilepsy. | Mol Chem Neuropathol | 1997 |
| 9184118 | Hippocampal connexin 43 expression in human complex partial seizure disorder. | Exp Neurol | 1997 |
| 9347980 | Cathepsin B and middle cerebral artery occlusion in the rat. | J Neurosurg | 1997 |
| 7862624 | Single cell monitoring of growth arrest and morphological changes induced by transfer of wild-type p53 alleles to glioblastoma cells. | Proc Natl Acad Sci U S A | 1995 |
| 7954439 | Cathepsin B expression and localization in glioma progression and invasion. | Cancer Res | 1994 |
| 8439970 | Turcot's syndrome of glioma and polyposis occurs in the absence of germ line mutations of exons 5 to 9 of the p53 gene. | Cancer Res | 1993 |